A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A genetic variant in the promoter of
CD46
is associated with the risk and prognosis of hepatocellular carcinoma
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 59, Issue 11, Pages 1243-1255
Publisher
Wiley
Online
2020-09-01
DOI
10.1002/mc.23252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors
- (2018) Aileen Baecker et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
- (2018) Jian Zhou et al. Liver Cancer
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer
- (2017) Weizhi Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma
- (2017) Ivan Pasic et al. MOLECULAR CARCINOGENESIS
- A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer
- (2016) Yanyan Zhang et al. Oncotarget
- Changing epidemiology of hepatocellular carcinoma in Asia
- (2015) George Boon-Bee Goh et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
- (2015) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- The tag SNP rs10746463 in decay-accelerating factor is associated with the susceptibility to gastric cancer
- (2015) Qinqin Song et al. MOLECULAR IMMUNOLOGY
- Complement Receptor 1 Genetic Variants Contribute to the Susceptibility to Gastric Cancer in Chinese Population
- (2015) Lina Zhao et al. Journal of Cancer
- A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age
- (2014) H. Ahsan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma
- (2014) Lei Hu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery
- (2014) Seung Duk Lee et al. Hepatobiliary & Pancreatic Diseases International
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46
- (2013) Shuai Zhang et al. FEBS LETTERS
- Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma
- (2013) ZEJUN LU et al. ONCOLOGY REPORTS
- Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
- (2013) Chung Hwan Jun WORLD JOURNAL OF GASTROENTEROLOGY
- Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
- (2013) Wen-jun Ma et al. World Journal of Surgical Oncology
- Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: A case-control study
- (2012) Fei Liu et al. INTERNATIONAL JOURNAL OF CANCER
- CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
- (2011) S R Park et al. BRITISH JOURNAL OF CANCER
- Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
- (2010) N. Geis et al. CURRENT CANCER DRUG TARGETS
- Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma
- (2010) Robert J. Clifford et al. HEPATOLOGY
- Hepatocellular carcinoma in the Asia pacific region
- (2009) Man-Fung Yuen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Primary human hepatocytes are protected against complement by multiple regulators
- (2009) Jarkko Halme et al. MOLECULAR IMMUNOLOGY
- Complement Receptor 1 (A3650GRsaI and Intron 27HindIII) Polymorphisms and Risk of Gallbladder Cancer in North Indian Population
- (2009) A. Srivastava et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A promoter polymorphism in the CASP8 gene is not associated with cancer risk
- (2008) Christopher A Haiman et al. NATURE GENETICS
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search